[144] SOPHiA GENETICS SA SEC Filing
Rhea-AI Filing Summary
JURGI CAMBLONG reported multiple 10b5-1 sales of Common stock executed through Morgan Stanley Smith Barney LLC as broker. The excerpt lists individual sales from 12/29/2025 through 03/16/2026 with per-trade share counts and proceeds.
Examples shown include sales of 95,488 shares on 01/09/2026 and 37,299 shares on 01/22/2026, executed under a 10b5-1 plan. The filing lists Restricted Stock Units and trade dates; cash-flow treatment is not stated in the provided excerpt.
Positive
- None.
Negative
- None.
Insights
Multiple planned sales under a 10b5-1 plan; routine disposition activity.
The excerpt documents sequential 10b5-1 sales by JURGI CAMBLONG through Morgan Stanley Smith Barney LLC with specific trade dates and share counts (for example, 95,488 shares on 01/09/2026). These are labeled as 10b5-1 sales, indicating pre-arranged trading instructions.
Impact depends on the holder's broader position and plan terms; subsequent filings or a Form 4 would show post-transaction holdings. Timing and proceeds recipient details are not included in the excerpt; further filings may provide the full position and cash‑flow specifics.